These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 21523807

  • 21. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP.
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [Abstract] [Full Text] [Related]

  • 22. Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: results from the North West London Sickle Cell Disease Registry.
    Gilmore A, Cho G, Howard J, Layton M, Afif M, Hughes RG, Philpott NJ, Patankar S, Davies SC, North West London Haemoglobinopathy Registry Group.
    Am J Hematol; 2011 Nov; 86(11):958-61. PubMed ID: 21948113
    [No Abstract] [Full Text] [Related]

  • 23. A simple index using age, hemoglobin, and aspartate transaminase predicts increased intracerebral blood velocity as measured by transcranial Doppler scanning in children with sickle cell anemia.
    Rees DC, Dick MC, Height SE, O'Driscoll S, Pohl KR, Goss DE, Deane CR.
    Pediatrics; 2008 Jun; 121(6):e1628-32. PubMed ID: 18490379
    [Abstract] [Full Text] [Related]

  • 24. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
    Wang WC, Morales KH, Scher CD, Styles L, Olivieri N, Adams R, Brambilla D, STOP Investigators.
    J Pediatr; 2005 Aug; 147(2):244-7. PubMed ID: 16126058
    [Abstract] [Full Text] [Related]

  • 25. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR.
    N Engl J Med; 1995 May 18; 332(20):1317-22. PubMed ID: 7715639
    [Abstract] [Full Text] [Related]

  • 26. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
    Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE.
    J Pediatr; 2001 Dec 18; 139(6):790-6. PubMed ID: 11743503
    [Abstract] [Full Text] [Related]

  • 27. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.
    Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, Ware RE.
    Am J Hematol; 2013 Feb 18; 88(2):116-9. PubMed ID: 23255310
    [Abstract] [Full Text] [Related]

  • 28. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J.
    JAMA; 2014 Sep 10; 312(10):1033-48. PubMed ID: 25203083
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
    Ballas SK, McCarthy WF, Guo N, Brugnara C, Kling G, Bauserman RL, Waclawiw MA.
    Hemoglobin; 2010 Sep 10; 34(5):424-9. PubMed ID: 20854115
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease.
    Bergmann S, Zheng D, Barredo J, Abboud MR, Jaffa AA.
    J Pediatr Hematol Oncol; 2006 Mar 10; 28(3):147-53. PubMed ID: 16679937
    [Abstract] [Full Text] [Related]

  • 34. Management of sickle cell disease.
    Steinberg MH.
    N Engl J Med; 1999 Apr 01; 340(13):1021-30. PubMed ID: 10099145
    [No Abstract] [Full Text] [Related]

  • 35. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP.
    Semin Hematol; 1997 Jul 01; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Impact of hydroxyurea on perioperative management and outcomes in children with sickle cell anemia.
    Hayashi M, Calatroni A, Herzberg B, Ross AK, Rice HE, Thornburg C.
    J Pediatr Hematol Oncol; 2011 Oct 01; 33(7):487-90. PubMed ID: 21941139
    [Abstract] [Full Text] [Related]

  • 39. Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease.
    McKie KT, Hanevold CD, Hernandez C, Waller JL, Ortiz L, McKie KM.
    J Pediatr Hematol Oncol; 2007 Mar 01; 29(3):140-4. PubMed ID: 17356390
    [Abstract] [Full Text] [Related]

  • 40. Splenectomy reduces packed red cell transfusion requirement in children with sickle cell disease.
    Haricharan RN, Roberts JM, Morgan TL, Aprahamian CJ, Hardin WD, Hilliard LM, Georgeson KE, Barnhart DC.
    J Pediatr Surg; 2008 Jun 01; 43(6):1052-6. PubMed ID: 18558181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.